Co-Diagnostics price target raised to $3 from $2 at H.C. Wainwright

H.C. Wainwright analyst Yi Chen raised the firm’s price target on Co-Diagnostics to $3 from $2 and keeps a Neutral rating on the shares following the Q3 beat. The analyst says the company’s strong cash position supports share repurchase.